US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 24.890
  • -1.110-4.27%
Close Sep 13 16:00 ET
  • 24.890
  • 0.0000.00%
Post 20:01 ET
731.73MMarket Cap-65500P/E (TTM)

Oruka Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
--15.12M
--27.74M
-Cash and cash equivalents
--15.12M
--27.74M
Receivables
--0
--0
Prepaid assets
--1.43M
----
Other current assets
--275K
----
Total current assets
--16.82M
--27.74M
Non current assets
Net PPE
--999K
----
-Gross PPE
--999K
----
Other non current assets
--2.36M
--488K
Total non current assets
--3.36M
--488K
Total assets
--20.18M
--28.23M
Liabilities
Current liabilities
Payables
--18.02M
--5.9M
-accounts payable
--2.58M
--5.9M
-Due to related parties current
--15.44M
----
Current accrued expenses
--795K
--1.13M
Current debt and capital lease obligation
--61K
----
-Current capital lease obligation
--61K
----
Other current liabilities
--430K
--56K
Current liabilities
--19.36M
--7.17M
Non current liabilities
Long term debt and capital lease obligation
--25.91M
--24.98M
-Long term debt
--24.98M
--24.98M
-Long term capital lease obligation
--925K
----
Non current accrued expenses
--961K
--214K
Preferred securities outside stock equity
--2.93M
--2.93M
Total non current liabilities
--29.8M
--28.13M
Total liabilities
--49.16M
--35.29M
Shareholders'equity
Share capital
--0
--1K
-common stock
--0
--1K
Retained earnings
---29.32M
---7.08M
Paid-in capital
--339K
--17K
Total stockholders'equity
---28.98M
---7.06M
Total equity
---28.98M
---7.06M
Currency Unit
USD
USD
Accounting Standards
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments --15.12M--27.74M
-Cash and cash equivalents --15.12M--27.74M
Receivables --0--0
Prepaid assets --1.43M----
Other current assets --275K----
Total current assets --16.82M--27.74M
Non current assets
Net PPE --999K----
-Gross PPE --999K----
Other non current assets --2.36M--488K
Total non current assets --3.36M--488K
Total assets --20.18M--28.23M
Liabilities
Current liabilities
Payables --18.02M--5.9M
-accounts payable --2.58M--5.9M
-Due to related parties current --15.44M----
Current accrued expenses --795K--1.13M
Current debt and capital lease obligation --61K----
-Current capital lease obligation --61K----
Other current liabilities --430K--56K
Current liabilities --19.36M--7.17M
Non current liabilities
Long term debt and capital lease obligation --25.91M--24.98M
-Long term debt --24.98M--24.98M
-Long term capital lease obligation --925K----
Non current accrued expenses --961K--214K
Preferred securities outside stock equity --2.93M--2.93M
Total non current liabilities --29.8M--28.13M
Total liabilities --49.16M--35.29M
Shareholders'equity
Share capital --0--1K
-common stock --0--1K
Retained earnings ---29.32M---7.08M
Paid-in capital --339K--17K
Total stockholders'equity ---28.98M---7.06M
Total equity ---28.98M---7.06M
Currency Unit USDUSD
Accounting Standards US-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data